WebIn 2016, an expert consensus panel from the ACC recommended the use of nonstatin therapies (ezetimibe and PCSK9 inhibitors) in addition to maximally tolerated statin therapy in individuals whose LDL-cholesterol and non-HDL-cholesterol levels remained above certain thresholds after statin treatment. WebJul 13, 2024 · ABSTRACT: Statins are a class of medications widely used for primary and secondary prevention of cardiovascular events. With six statins available generically, the …
Safety and efficacy of statin therapy - PubMed
WebDec 15, 2024 · All patients with DM (age 40-75) with LDL-C 70-189, without known CVD, should receive moderate-intensity statin, or if 10-year risk by ASCVD risk calculator is > 7.5%, high-intensity statin. Patients age 40-75 without diabetes or CVD, but with LDL-C 70-189 and 10-year risk >7.5%, should consider a moderate-to-high intensity statin. WebSep 26, 2024 · High‐intensity statin use was defined as atorvastatin ≥40 mg or rosuvastatin ≥20 mg daily; and moderate‐intensity statin use was defined as 10 mg ≤atorvastatin <40 mg, 5 mg ≤rosuvastatin <20 mg, simvastatin ≥20 mg, pravastatin ≥40 mg, lovastatin ≥40 mg, fluvastatin ≥80 mg, or pitavastatin ≥2 mg daily. Statistical Analysis oxnard college men\u0027s soccer
Key Recommendations on Managing Dyslipidemia for …
WebAug 17, 2024 · Your doctor may recommend taking moderate-intensity statins if: You are between 40 and 75 years old. You don’t have diabetes. Your LDL-C levels are at or above 70 mg/dL. You have a 10-year... Web2024 Aug;43(4):556-570. doi: 10.1111/jcpt.12690. Epub 2024 May 7. ... moderate-intensity or high-intensity statin therapy should be used as the primary prevention for individuals with diabetes mellitus, aged between 40 and 75 years and with low-density lipoprotein cholesterol (LDL-C) from 70 to 189 mg/dL. ... WebFeb 26, 2024 · • Moderate-intensity statin therapy should be initiated without calculating a 10-year ASCVD risk for patients 40 to 75 years of age with diabetes mellitus. ... 2024 … jefferson county tax map ny